The Centers for Disease Control and Prevention (CDC) have concluded that dozens of Johnson & Johnson vaccine recipients have had adverse reactions physically due to anxiety and not the vaccine itself, according to a report published Friday.
The agency examined a total of 64 of the 8,624 events reported to the CDC by five vaccination sites in five different states.
The researchers say that these anxiety-related cases “can occur after any vaccination” if a person has a physical reaction within 15 minutes of vaccination due to concerns about being vaccinated.
The incident was reported between April 7 and 9, about five weeks after the Food and Drug Administration (FDA) issued emergency approval for the Johnson & Johnson vaccine.
These anxiety-related reactions were unrelated to rare cases of blood clots, prompting the CDC and the FDA to temporarily discontinue administration of Johnson & Johnson vaccines nationwide. An anxiety-related case preceded the pause that ended last week.
In response to anxiety-related cases, including 17 fainting or syncope, four out of five vaccination sites were temporarily shut down during the investigation.
Overall, the CDC states that the reported fainting rate after exposure to Johnson & Johnson’s vaccine to the vaccine adverse event reporting system was 8.2 per 100,000 doses.In comparison, the 2018-2020 influenza vaccination rate was 0.05. Per 100,000 doses, which is about 164 times less than normal.
Recipients who received most anxiety-related events reported fainting or dizziness, sweating, fainting, nausea, vomiting, and hypotension. Thirteen patients were taken to the emergency department for further care.
The researchers noted that because Johnson & Johnson is the only injectable drug available in the United States, people with needle aversion may be more selective and are more likely to have an event related to it. Anxiety after vaccination
They called on vaccine providers to “be aware” of post-vaccination anxiety-related events and to observe all recipients of any reactions for at least 15 minutes after vaccination.
The Associated Press Identify the five states where the incident occurred, such as California, Colorado, Georgia, Iowa, and North Carolina.
The anxiety-related incidents were different from at least 17 Johnson & Johnson vaccine recipients who developed rare blood clotting in abnormal locations and low platelet levels. Last week, the FDA included warnings for most of these coagulation cases in women ages 18 to 49 due to resuming the Johnson & Johnson vaccine.
Johnson & Johnson vaccine recipients also reported less serious side effects, such as arm pain, fatigue and headache, as did people who received the vaccine. Pfizer-BioNTech and Moderna